| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-29 |
详情>>
业绩披露：
2020年年报每股收益3.92美元,归母净利润1.52亿美元,同比去年增长9.71%
|
| 2021-01-25 |
股东大会：
将于2021-03-01召开股东大会
会议内容 ▼▲
- 1.To consider and vote on, among other matters, the proposal to authorize and approve the previously announced agreement and plan of merger, dated as of November 19, 2020 (the “Merger Agreement”), among the Company, CBPO Holdings Limited (“Parent”) and CBPO Group Limited (“Merger Sub”), the plan of merger required to be filed with the Registrar of Companies of the Cayman Islands (the “Plan of Merger”) and the transactions contemplated thereby, including the Merger
|
| 2020-11-24 |
详情>>
股本变动：
变动后总股本3878.81万股
|
| 2020-11-24 |
详情>>
业绩披露：
2020年三季报(累计)每股收益3.31美元,归母净利润1.29亿美元,同比去年增长1.78%
|
| 2020-08-17 |
财报披露：
美东时间 2020-08-17 盘后发布财报
|
| 2020-08-17 |
详情>>
业绩披露：
2020年中报每股收益2.29美元,归母净利润8906.61万美元,同比去年增长12.26%
|
| 2020-05-20 |
详情>>
业绩披露：
2020年一季报每股收益1.38美元,归母净利润5338.44万美元,同比去年增长41.63%
|
| 2020-03-12 |
详情>>
业绩披露：
2019年年报每股收益3.55美元,归母净利润1.39亿美元,同比去年增长8.40%
|
| 2020-03-12 |
详情>>
业绩披露：
2017年年报每股收益2.40美元,归母净利润6794.30万美元,同比去年增长-35.16%
|
| 2019-11-13 |
详情>>
业绩披露：
2019年三季报(累计)每股收益3.22美元,归母净利润1.26亿美元,同比去年增长35.65%
|
| 2019-09-19 |
复牌提示：
2019-09-18 16:00:11 停牌，复牌日期 2019-09-18 16:30:00
|
| 2019-08-05 |
详情>>
业绩披露：
2019年中报每股收益2.01美元,归母净利润7933.93万美元,同比去年增长31.73%
|
| 2019-05-15 |
股东大会：
将于2019-06-28召开股东大会
会议内容 ▼▲
- 1.as an ordinary resolution:
THAT Joseph Chow be appointed as a Class I director of the Company with immediate effect, to serve until the 2022 annual general meeting of the shareholders of the Company and until his successor shall have been duly elected, subject to his earlier death, resignation, retirement or removal.
2.as an ordinary resolution:
THAT Yue’e Zhang be appointed as a Class I director of the Company with immediate effect, to serve until the 2022 annual general meeting of the shareholders of the Company and until her successor shall have been duly elected, subject to her earlier death, resignation, retirement or removal.
3.as an ordinary resolution:
THAT the appointment of KPMG Huazhen LLP, which was selected by the Audit Committee, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019 is hereby approved and ratified.
|
| 2019-05-10 |
详情>>
业绩披露：
2019年一季报每股收益0.94美元,归母净利润3769.21万美元,同比去年增长19.34%
|
| 2019-03-06 |
详情>>
业绩披露：
2018年年报每股收益3.54美元,归母净利润1.28亿美元,同比去年增长88.48%
|
| 2018-05-07 |
股东大会：
将于2018-06-29召开股东大会
会议内容 ▼▲
- 1.as an ordinary resolution:
THAT Yungang Lu be appointed as a Class III Director of the Company with immediate effect, to serve until the 2021 annual general meeting of the shareholders of the Company, until his successor shall have been duly elected and qualified, or until his earlier resignation or removal.
2.as an ordinary resolution:
THAT Zhijun Tong be appointed as a Class III Director of the Company with immediate effect, to serve until the 2021 annual general meeting of the shareholders of the Company, until his successor shall have been duly elected and qualified, or until his earlier resignation or removal.
3.as an ordinary resolution:
THAT Albert (Wai Keung) Yeung be appointed as a Class III Director of the Company with immediate effect, to serve until the 2021 annual general meeting of the shareholders of the Company, until his successor shall have been duly elected and qualified, or until his earlier resignation or removal.
4.as an ordinary resolution:
THAT the appointment of KPMG Huazhen LLP, which was selected by the Audit Committee, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018 is hereby approved and ratified.
|
| 2017-05-19 |
股东大会：
将于2017-06-30召开股东大会
会议内容 ▼▲
- 1. to elect the three individuals listed in the accompanying proxy statement/prospectus to the Board of Directors of the Company, each to serve until the 2020 annual meeting of stockholders of the Company or until such person shall resign, be removed or otherwise leave office;
2. to ratify the selection by the Audit Committee of KPMG Huazhen LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017;
3. to have an advisory vote to approve the compensation of our named executive officers for the year ended December 31, 2016;
4. to have an advisory vote on the frequency of holding an advisory vote on executive compensation;
5. to approve and adopt the agreement and plan of merger (the “Merger Agreement”) by and between the Company and China Biologic Products Holdings, Inc., an exempted company incorporated under the laws of the Cayman Islands and a wholly owned subsidiary of the Company (“CBPO Cayman”), which included a plan of merger required to be filed with the Register of Companies of the Cayman Islands, substantially in the form as attached as Annex A to the Merger Agreement (the “Plan of Merger”), pursuant to which the Company will merge with and into CBPO Cayman, with CBPO Cayman as the surviving company upon the merger becoming effective, and whereby each issued and outstanding share of the common stock of the Company will be converted into the right to receive one ordinary share of CBPO Cayman (the “Redomicile Merger”);
6. to transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2016-04-29 |
股东大会：
将于2016-06-20召开股东大会
会议内容 ▼▲
- 1.to elect the three individuals listed in the accompanying Proxy Statement to the Board of Directors of the Company, each to serve until the 2019 annual meeting of stockholders of the Company or until such person shall resign, be removed or otherwise leave office;
2.to ratify the selection by the Audit Committee of KPMG Huazhen LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016;
3.to have an advisory vote to approve the compensation of our named executive officers for the year ended December 31, 2015;
4.to approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to effect an increase in the total number of authorized shares of common stock from 100,000,000 to 1,000,000,000, with the effectiveness or abandonment of such amendment to be determined by the Board of Directors as permitted under Section 242(c) of the Delaware General Corporation Law;
5.to transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2015-04-29 |
股东大会：
将于2015-06-19召开股东大会
会议内容 ▼▲
- 1.To elect the three individuals listed in the accompanying Proxy Statement to the Board of Directors of the Company, each to serve until the 2018 annual meeting of stockholders of the Company or until such person shall resign, be removed or otherwise leave office;
2.To ratify the selection by the Audit Committee of KPMG as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2015;
3.To have an advisory vote to approve the compensation of the company's named executive officers for the year ended December 31, 2014;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2014-04-23 |
股东大会：
将于2014-06-20召开股东大会
会议内容 ▼▲
- 1. To elect the three individuals listed in the accompanying Proxy Statement to the Board of Directors of the Company, each to serve until the 2017 annual meeting of stockholders of the Company or until such person shall resign, be removed or otherwise leave office;
2. To ratify the selection by the Audit Committee of KPMG as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2014;
3. To have an advisory vote to approve the compensation of our named executive officers for the year ended December 31, 2013;
4. To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2013-04-30 |
股东大会：
将于2013-06-28召开股东大会
会议内容 ▼▲
- 1. To elect the three individuals listed in the accompanying Proxy Statement to the Board of Directors of the Company, each to serve until the 2016 annual meeting of stockholders of the Company or until such person shall resign, be removed or otherwise leave office;
2. To ratify the selection by the Audit Committee of KPMG as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2013;
3. To have an advisory vote to approve the compensation of our named executive officers for the year ended December 31, 2012;
4. To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|